Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 781683, 8 pages
http://dx.doi.org/10.1155/2014/781683
Review Article

Aging: A Predisposition to Dry Eyes

1Flaum Eye Institute, University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Rochester, NY 14642, USA
2Center for Visual Science, University of Rochester School of Medicine and Dentistry, Rochester, NY 14642, USA

Received 6 June 2014; Revised 23 July 2014; Accepted 31 July 2014; Published 14 August 2014

Academic Editor: Mainak Sengupta

Copyright © 2014 Anushree Sharma and Holly B. Hindman. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. A. Smith, J. Albenz, C. Begley et al., “The epidemiology of dry eye disease: Report of the epidemiology subcommittee of the international Dry Eye WorkShop (2007),” Ocular Surface, vol. 5, no. 2, pp. 93–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. J. Paulsen, K. J. Cruickshanks, M. E. Fischer et al., “Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life,” American Journal of Ophthalmology, vol. 157, no. 4, pp. 799–806, 2014. View at Publisher · View at Google Scholar
  3. S. E. Moss, R. Klein, and B. E. K. Klein, “Prevalance of and risk factors for dry eye syndrome,” Archives of Ophthalmology, vol. 118, no. 9, pp. 1264–1268, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Buchholz, C. S. Steeds, L. S. Stern et al., “Utility assessment to measure the impact of dry eye disease,” Ocular Surface, vol. 4, no. 3, pp. 155–161, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. Q. Ivers, R. G. Cumming, P. Mitchell, and K. Attebo, “Visual impairment and falls in older adults: the blue mountains eye study,” Journal of the American Geriatrics Society, vol. 46, no. 1, pp. 58–64, 1998. View at Google Scholar · View at Scopus
  6. B. E. Klein, R. Klein, K. E. Lee, and K. J. Cruickshanks, “Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time: the Beaver Dam Eye Study,” Ophthalmology, vol. 105, no. 1, pp. 160–164, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. C. A. McCarty, C. L. Fu, and H. R. Taylor, “Predictors of falls in the Melbourne Visual impairment project,” Australian and New Zealand Journal of Public Health, vol. 26, no. 2, pp. 116–119, 2002. View at Google Scholar · View at Scopus
  8. D. T. Felson, J. J. Anderson, M. T. Hannan, R. C. Milton, P. W. F. Wilson, and D. P. Kiel, “Impaired vision and hip fracture. The Framingham study,” Journal of the American Geriatrics Society, vol. 37, no. 6, pp. 495–500, 1989. View at Google Scholar · View at Scopus
  9. J. Yu, C. V. Asche, and C. J. Fairchild, “The economic burden of dry eye disease in the United States: a decision tree analysis,” Cornea, vol. 30, no. 4, pp. 379–387, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. S. R. Drummond, R. S. Drummond, and G. N. Dutton, “Visual acuity and the ability of the visually impaired to read medication instructions,” British Journal of Ophthalmology, vol. 88, no. 12, pp. 1541–1542, 2004. View at Publisher · View at Google Scholar · View at Scopus
  11. D. A. Schaumberg, “Epidemiology of dry eye disease and the patient's perspective,” Johns Hopkins Advanced Studies in Ophthalmology, vol. 9, no. 1, p. 4, 2012. View at Google Scholar
  12. P. Mertzanis, L. Abetz, K. Rajagopalan et al., “The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample,” Investigative Ophthalmology and Visual Science, vol. 46, no. 1, pp. 46–50, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Miljanović, R. Dana, D. A. Sullivan, and D. A. Schaumberg, “Impact of dry eye syndrome on vision-related quality of life,” American Journal of Ophthalmology, vol. 143, no. 3, pp. 409–415, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Tong, S. Waduthantri, T. Y. Wong et al., “Impact of symptomatic dry eye on vision-related daily activities: the Singapore Malay Eye Study,” Eye, vol. 24, no. 9, pp. 1486–1491, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. S. C. Pflugfelder, “Tear dysfunction and the cornea: LXVIII Edward Jackson memorial lecture,” American Journal of Ophthalmology, vol. 152, no. 6, pp. 900.e1–909.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Driver and M. A. Lemp, “Meibomian gland dysfunction,” Survey of Ophthalmology, vol. 40, no. 5, pp. 343–367, 1996. View at Publisher · View at Google Scholar · View at Scopus
  17. G. N. Foulks, K. K. Nichols, A. J. Bron, E. J. Holland, M. B. McDonald, and J. Daniel Nelson, “Improving awareness, identification, and management of meibomian gland dysfunction,” Ophthalmology, vol. 119, no. 10, pp. S1–S12, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Shinohara, R. Kominami, S. Yasutaka, and Y. Taniguchi, “The anatomy of the lacrimal portion of the orbicularis oculi muscle (tensor tarsi or Horner’s muscle),” Okajimas Folia Anatomica Japonica, vol. 77, no. 6, pp. 225–232, 2000. View at Google Scholar · View at Scopus
  19. M. Lemp and G. Foulks, “The definition & classification of dry eye disease,” in Guidelines from the 2007 International Dry Eye Workshop, 2008. View at Google Scholar
  20. A. Tomlinson, S. Khanal, K. Ramaesh, C. Diaper, and A. McFadyen, “Tear film osmolarity: determination of a referent for dry eye diagnosis,” Investigative Ophthalmology and Visual Science, vol. 47, no. 10, pp. 4309–4315, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Guzman-Aranguez and P. Argüeso, “Structure and biological roles of mucin-type O-glycans at the ocular surface,” Ocular Surface, vol. 8, no. 1, pp. 8–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Contreras-Ruiz, A. Ghosh-Mitra, M. A. Shatos, D. A. Dartt, and S. Masli, “Modulation of conjunctival goblet cell function by inflammatory cytokines,” Mediators of Inflammation, vol. 2013, Article ID 636812, 11 pages, 2013. View at Publisher · View at Google Scholar
  23. L. Contreras-Ruiz, B. Regenfuss, F. A. Mir, J. Kearns, and S. Masli, “Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjogren's syndrome,” PLoS ONE, vol. 8, no. 9, Article ID e75937, 2013. View at Google Scholar
  24. X. Zhang, W. Chen, C. S. de Paiva et al., “Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways,” Investigative Ophthalmology and Visual Science, vol. 52, no. 9, pp. 6279–6285, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Zhu, J. Hong, T. Zheng, Q. Le, J. Xu, and X. Sun, “Age-related changes of human conjunctiva on in vivo confocal microscopy,” British Journal of Ophthalmology, vol. 94, no. 11, pp. 1448–1453, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Giebel, C. Woenckhaus, M. Fabian, and F. Tost, “Age-related differential expression of apoptosis-related genes in conjunctival epithelial cells,” Acta Ophthalmologica Scandinavica, vol. 83, no. 4, pp. 471–476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. Q. Gu, C. F. Dillon, and V. L. Burt, “Prescription drug use continues to increase: US prescription drug data for 2007-2008,” NCHS Data Brief, no. 42, pp. 1–8, 2010. View at Google Scholar · View at Scopus
  28. National Center for Health Statistics. Health, United States, 2013.
  29. A. Somogyi, D. Hewson, M. Muirhead, and F. Bochner, “Amiloride disposition in geriatric patients: importance of renal function,” British Journal of Clinical Pharmacology, vol. 29, no. 1, pp. 1–8, 1990. View at Publisher · View at Google Scholar · View at Scopus
  30. A. A. Mangoni and S. H. D. Jackson, “Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications,” British Journal of Clinical Pharmacology, vol. 57, no. 1, pp. 6–14, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. S. E. Moss, R. Klein, and B. Klein, “Long-term incidence of dry eye in an older population,” Optometry & Vision Science, vol. 85, no. 8, pp. 668–674, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Mrugacz, L. Ostrowska, J. Łazarczyk-Kirejczyk et al., “Dry eye disease in patients treated with antidepressants,” Klinika Oczna, vol. 115, no. 2, pp. 111–114, 2013. View at Google Scholar
  33. F. T. Fraunfelder, J. J. Sciubba, and W. D. Mathers, “The role of medications in causing dry eye,” Journal of Ophthalmology, vol. 2012, Article ID 285851, 8 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. H. A. Quigley, “Number of people with glaucoma worldwide,” British Journal of Ophthalmology, vol. 80, no. 5, pp. 389–393, 1996. View at Publisher · View at Google Scholar · View at Scopus
  35. E. W. Leung, F. A. Medeiros, and R. N. Weinreb, “Prevalence of ocular surface disease in glaucoma patients,” Journal of Glaucoma, vol. 17, no. 5, pp. 350–355, 2008. View at Publisher · View at Google Scholar
  36. M. Zemba, C. A. Papadatu, V. E. Enache, and L. N. Sârbu, “Ocular surface in glaucoma patients with topical treatment,” Oftalmologia, vol. 55, no. 3, pp. 94–98, 2011. View at Google Scholar · View at Scopus
  37. C. Baudouin, A. Labbé, H. Liang, A. Pauly, and F. Brignole-Baudouin, “Preservatives in eyedrops: the good, the bad and the ugly,” Progress in Retinal and Eye Research, vol. 29, no. 4, pp. 312–334, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. I. R. Schwab, J. V. Linberg, V. M. Gioia, W. H. Benson, and G. M. Chao, “Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications,” Ophthalmology, vol. 99, no. 2, pp. 197–202, 1992. View at Publisher · View at Google Scholar · View at Scopus
  39. R. D. Fechtner, D. G. Godfrey, D. Budenz, J. A. Stewart, W. C. Stewart, and M. C. Jasek, “Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications,” Cornea, vol. 29, no. 6, pp. 618–621, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. D. A. Schaumberg, R. Dana, J. E. Buring, and D. A. Sullivan, “Prevalence of dry eye disease among US men: Estimates from the physicians' health studies,” Archives of Ophthalmology, vol. 127, no. 6, pp. 763–768, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. D. A. Schaumberg, D. A. Sullivan, J. E. Buring, and M. R. Dana, “Prevalence of dry eye syndrome among US women,” American Journal of Ophthalmology, vol. 136, no. 2, pp. 318–326, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. D. A. Sullivan, R. V. Jensen, T. Suzuki, and S. M. Richards, “Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands?” Molecular Vision, vol. 15, pp. 1553–1572, 2009. View at Google Scholar · View at Scopus
  43. T. Suzuki, F. Schirra, S. M. Richards et al., “Estrogen’s and progesterone’s impact on gene expression in the mouse lacrimal gland,” Investigative Ophthalmology & Visual Science, vol. 47, pp. 158–168, 2006. View at Google Scholar
  44. S. T. Valtysdottir, L. Wide, and R. Hallgren, “Mental wellbeing and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate,” Annals of the Rheumatic Diseases, vol. 62, no. 9, pp. 875–879, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. P. M. Azcarate, V. D. Venincasa, A. Galor et al., “Androgen deficiency and dry eye syndrome in the aging male,” Investigative Ophthalmology & Visual Science, 2014. View at Publisher · View at Google Scholar
  46. F. Labrie, A. Bélanger, L. Cusan, J. Gomez, and B. Candas, “Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging,” Journal of Clinical Endocrinology and Metabolism, vol. 82, no. 8, pp. 2396–2402, 1997. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Shinohara, R. Kominami, S. Yasutaka, and Y. Taniguchi, “The Anatomy of the Lacrimal Portion of the Orbicularis Oculi Muscle (Tensor Tarsi or Horner's Muscle),” Okajimas Folia Anatomica Japonica, vol. 77, no. 6, pp. 225–232, 2000. View at Google Scholar · View at Scopus
  48. RW. Damasceno, MH. Osaki, PE. Dantas, and R. Belfort Jr., “Involutional entropion and ectropion of the lower eyelid: prevalence and associated risk factors in the elderly population,” Ophthalmic Plastic & Reconstructive Surgery, vol. 27, no. 5, pp. 317–320, 2011. View at Publisher · View at Google Scholar
  49. E. Villani, V. Canton, F. Magnani, F. Viola, P. Nucci, and R. Ratiglia, “The aging meibomian gland: an in vivo confocal study,” Investigative Ophthalmology and Visual Science, vol. 54, no. 7, pp. 4735–4740, 2013. View at Publisher · View at Google Scholar · View at Scopus
  50. P. J. Murphy, S. Patel, N. Kong, R. E. J. Ryder, and J. Marshall, “Noninvasive assessment of corneal sensitivity in young and elderly diabetic and nondiabetic subjects,” Investigative Ophthalmology and Visual Science, vol. 45, no. 6, pp. 1737–1742, 2004. View at Publisher · View at Google Scholar · View at Scopus
  51. D. Meller and S. C. G. Tseng, “Conjunctivochalasis: literature review and possible pathophysiology,” Survey of Ophthalmology, vol. 43, no. 3, pp. 225–232, 1998. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Mimura, S. Yamagami, T. Usui et al., “Changes of conjunctivochalasis with age in a hospital-based study,” The American Journal of Ophthalmology, vol. 147, no. 1, pp. 171.e1–177.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. A. Wollenberg, “Pseudopterygium mit Faltenbildung der Conjunctiva bulbi,” Klinische Monatsblätter für Augenheilkunde, vol. 68, pp. 221–224, 1922. View at Google Scholar
  54. D. R. Jordan and C. R. Pelletier, “Conjunctivochalasis,” Canadian Journal of Ophthalmology, vol. 31, no. 4, pp. 192–193, 1996. View at Google Scholar · View at Scopus
  55. A. M. Roszkowska, P. Colosi, F. M. B. Ferreri, and S. Galasso, “Age-related modifications of corneal sensitivity,” Ophthalmologica, vol. 218, no. 5, pp. 350–355, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. A. Labbé, H. Alalwani, C. van Went, E. Brasnu, D. Georgescu, and C. Baudouin, “The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease,” Investigative Ophthalmology and Visual Science, vol. 53, no. 8, pp. 4926–4931, 2012. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Bourcier, M. C. Acosta, V. Borderie et al., “Decreased corneal sensitivity in patients with dry eye,” Investigative Ophthalmology and Visual Science, vol. 46, no. 7, pp. 2341–2345, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. C. S. De Paiva and S. C. Pflugfelder, “Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation,” American Journal of Ophthalmology, vol. 137, no. 1, pp. 109–115, 2004. View at Publisher · View at Google Scholar · View at Scopus
  59. I. S. Tuisku, Y. T. Konttinen, L. M. Konttinen, and T. M. Tervo, “Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome,” Experimental Eye Research, vol. 86, no. 6, pp. 879–885, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. I. S. J. Tuominen, Y. T. Konttinen, M. H. Vesaluoma, J. A. Moilanen, M. Helintö, and T. M. Tervo, “Corneal innervation and morphology in primary Sjögren's syndrome,” Investigative Ophthalmology & Visual Science, vol. 44, no. 6, pp. 2545–2549, 2003. View at Google Scholar
  61. J. M. B. del Castillo, M. A. S. Wasfy, C. Fernandez, and J. Garcia-Sanchez, “An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye,” Investigative Ophthalmology and Visual Science, vol. 45, no. 9, pp. 3030–3035, 2004. View at Publisher · View at Google Scholar · View at Scopus
  62. S. K. van den Eeden, C. M. Tanner, A. L. Bernstein et al., “Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity,” American Journal of Epidemiology, vol. 157, no. 11, pp. 1015–1022, 2003. View at Publisher · View at Google Scholar · View at Scopus
  63. V. C. Reddy, S. V. Patel, D. O. Hodge, and J. A. Leavitt, “Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and parkinson disease,” Cornea, vol. 32, no. 5, pp. 631–635, 2013. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Labbé, Q. Liang, Z. Wang et al., “Corneal nerve structure and function in patients with non-sjögren dry eye: clinical correlations,” Investigative Ophthalmology & Visual Science, vol. 54, no. 8, pp. 5144–5150, 2013. View at Google Scholar
  65. M. Dogru, T. Wakamatsu, T. Kojima et al., “The role of oxidative stress and inflammation in dry eye disease,” Cornea, vol. 28, no. 1, pp. S70–S74, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. M. L. Massingale, X. Li, M. Vallabhajosyula, D. Chen, Y. Wei, and P. A. Asbell, “Analysis of inflammatory cytokines in the tears of dry eye patients,” Cornea, vol. 28, no. 9, pp. 1023–1027, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. H. Lam, L. Bleiden, C. S. de Paiva, W. Farley, M. E. Stern, and S. C. Pflugfelder, “Tear cytokine profiles in dysfunctional tear syndrome,” The American Journal of Ophthalmology, vol. 147, no. 2, pp. 198.e1–205.e1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. C. S. De Paiva, A. L. Villarreal, R. M. Corrales et al., “Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-γ,” Investigative Ophthalmology and Visual Science, vol. 48, no. 6, pp. 2553–2560, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. V. Morrisette-Thomas, A. A. Cohen, T. Fülöp et al., “Inflamm-aging does not simply reflect increases in pro-inflammatory markers,” Mechanisms of Ageing and Development, vol. 139, pp. 49–57, 2014. View at Publisher · View at Google Scholar
  70. S. Nakamura, M. Shibuya, H. Nakashima et al., “Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye,” Investigative Ophthalmology & Visual Science, vol. 48, no. 4, pp. 1552–1558, 2007. View at Publisher · View at Google Scholar · View at Scopus
  71. M. Pinazo-Duran, R. Gallego-Pinazo, J. J. García-Medina et al., “Oxidative stress and its downstream signaling in aging eyes,” Clinical Interventions in Aging, vol. 9, pp. 637–652, 2014. View at Publisher · View at Google Scholar
  72. D. D. Altinors, S. Akça, Y. A. Akova et al., “Smoking associated with damage to the lipid layer of the ocular surface,” The American Journal of Ophthalmology, vol. 141, no. 6, pp. 1016.e1–1021.e1, 2006. View at Publisher · View at Google Scholar · View at Scopus
  73. Cochrane Database of Systematic Reviews: Reviews, John Wiley & Sons, 1996, http://one.aao.org/preferred-practice-pattern/dry-eye-syndrome-ppp–2013.
  74. S. Matsuda and S. Koyasu, “Mechanisms of action of cyclosporine,” Immunopharmacology, vol. 47, no. 2-3, pp. 119–125, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. K. Sall, O. D. Stevenson, T. K. Mundorf, and B. L. Reis, “Two multicenter randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease,” Ophthalmology, vol. 107, no. 4, pp. 631–639, 2000. View at Publisher · View at Google Scholar · View at Scopus
  76. S. C. Pflugfelder, S. L. Maskin, B. Anderson et al., “A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance,” The American Journal of Ophthalmology, vol. 138, no. 3, pp. 444–457, 2004. View at Publisher · View at Google Scholar · View at Scopus
  77. F. Chen, J. Wang, W. Chen, M. Shen, S. Xu, and F. Lu, “Upper punctal occlusion versus lower punctal occlusion in dry eye,” Investigative Ophthalmology and Visual Science, vol. 51, no. 11, pp. 5571–5577, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. F. B. Vivino, I. Al-Hashimi, Z. Khan et al., “Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjogren syndrome: a randomized, placebo-controlled, fixed- dose, multicenter trial,” Archives of Internal Medicine, vol. 159, no. 2, pp. 174–181, 1999. View at Publisher · View at Google Scholar · View at Scopus
  79. D. Petrone, J. J. Condemi, R. Fife, O. Gluck, S. Cohen, and P. Dalgin, “A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca,” Arthritis and Rheumatism, vol. 46, no. 3, pp. 748–754, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. K. Tsubota, E. Goto, H. Fujita et al., “Treatment of dry eye by autologous serum application in Sjogren's syndrome,” British Journal of Ophthalmology, vol. 83, no. 4, pp. 390–395, 1999. View at Publisher · View at Google Scholar · View at Scopus
  81. L. Oprea, A. Tiberghien, C. Creuzot-Garcher, and C. Baudouin, “Hormonal regulatory influence in tear film,” Journal Francais d'Ophtalmologie, vol. 27, no. 8, pp. 933–941, 2004. View at Publisher · View at Google Scholar · View at Scopus
  82. E. M. Rocha, F. Mantelli, L. F. Nominato, and S. Bonini, “Hormones and dry eye syndrome: an update on what we do and don't know,” Current Opinion in Ophthalmology, vol. 24, no. 4, pp. 348–355, 2013. View at Publisher · View at Google Scholar · View at Scopus
  83. G. Uncu, R. Avci, Y. Uncu, C. Kaymaz, and O. Develioǧlu, “The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity,” Gynecological Endocrinology, vol. 22, no. 9, pp. 501–505, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. G. Scuderi, M. T. Contestabile, C. Gagliano, D. Iacovello, L. Scuderi, and T. Avitabile, “Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial,” Canadian Journal of Ophthalmology, vol. 47, no. 6, pp. 489–492, 2012. View at Publisher · View at Google Scholar · View at Scopus
  85. M. A. Nanavaty, M. Long, and R. Malhotra, “Transdermal androgen patches in evaporative dry eye syndrome with androgen deficiency: a pilot study,” British Journal of Ophthalmology, vol. 98, pp. 567–569, 2014. View at Google Scholar
  86. K. Barton, D. C. Monroy, A. Nava, and S. C. Pflugfelder, “Inflammatory cytokines in tears of patients with ocular rosacea,” Ophthalmology, vol. 104, pp. 1868–1874, 1997. View at Google Scholar